Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page header/footer revision was updated from **v3.5.2** to **v3.5.3**, indicating a technical release/version change rather than a change to the study record content.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0; no visible changes to study content or eligibility criteria.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded the topic keyword 'Amyloidosis' and updated the page revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedMinor version update from v3.4.0 to v3.4.1; no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.